TFPI Antikörper (AA 101-200) (Cy5)
-
- Target Alle TFPI Antikörper anzeigen
- TFPI (Tissue Factor Pathway Inhibitor (Lipoprotein-Associated Coagulation Inhibitor) (TFPI))
-
Bindungsspezifität
- AA 101-200
-
Reaktivität
- Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TFPI Antikörper ist konjugiert mit Cy5
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Maus, Ratte
- Homologie
- Human,Cow,Pig,Horse,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human TFPI
- Isotyp
- IgG
- Top Product
- Discover our top product TFPI Primärantikörper
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- TFPI (Tissue Factor Pathway Inhibitor (Lipoprotein-Associated Coagulation Inhibitor) (TFPI))
- Andere Bezeichnung
- Tfpi/Laci (TFPI Produkte)
- Synonyme
- EPI antikoerper, LACI antikoerper, TFI antikoerper, TFPI1 antikoerper, A630013F22Rik antikoerper, AW552122 antikoerper, TFPI antikoerper, si:dz44f8.1 antikoerper, tfpib antikoerper, wu:fb92g01 antikoerper, zgc:152844 antikoerper, zgc:158592 antikoerper, tissue factor pathway inhibitor antikoerper, tissue factor pathway inhibitor a antikoerper, TFPI antikoerper, Tfpi antikoerper, tfpia antikoerper
- Hintergrund
-
Synonyms: EPI, TFI, LACI, TFPI1, Tissue factor pathway inhibitor, TFPI, Extrinsic pathway inhibitor, Lipoprotein-associated coagulation inhibitor
Background: Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma.
- Gen-ID
- 7035
- UniProt
- P10646
-